Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

Researchers say a woman struggling with obesity who couldn't resist eating fatty foods experienced declines in her cravings after taking tirzepatide.

The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...

The Therapeutic Goods Administration issued a new warning for GLP-1 receptor agonists, including Ozempic and Mounjaro, on ...

Australia's medicines regulator issues a safety warning over the potential risk of suicidal thoughts and behaviours when ...

Some online clinics claim convenience and confidentiality as benefits, but charge a premium for being the middleman for a ...

The recommended discontinuation of GLP-1 receptor agonists during pregnancy was associated with more gestational weight gain ...

The WHO’s announcement came hours after Australia released a safety alert over the potential risk of suicidal thoughts and behaviours for people using the medicines.

The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.